Kwang‐hyub Han
#138,460
Most Influential Person Now
Kwang‐hyub Han's AcademicInfluence.com Rankings
Kwang‐hyub Hanphilosophy Degrees
Philosophy
#7110
World Rank
#10272
Historical Rank
Logic
#4184
World Rank
#5445
Historical Rank
Download Badge
Philosophy
Kwang‐hyub Han's Degrees
- Doctorate Medicine Seoul National University
- PhD Medicine Seoul National University
Why Is Kwang‐hyub Han Influential?
(Suggest an Edit or Addition)Kwang‐hyub Han's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial (2018) (2744)
- A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. (2006) (1375)
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017) (1338)
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update (2012) (1019)
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update (2008) (926)
- Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B (2010) (870)
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. (2015) (697)
- Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study. (2013) (649)
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. (2017) (603)
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt (2011) (517)
- Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. (2011) (508)
- Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. (2007) (370)
- Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) (2011) (288)
- Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis (2012) (264)
- Dose-response relationship in local radiotherapy for hepatocellular carcinoma. (2001) (256)
- Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. (2012) (251)
- Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). (2015) (244)
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission (2019) (227)
- Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011) (2016) (219)
- A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis (2010) (213)
- Liver cancer: Approaching a personalized care. (2015) (210)
- NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome. (2017) (204)
- A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea (2012) (187)
- Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. (2005) (183)
- Validation of FIB‐4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus‐infected patients (2010) (167)
- Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage (2014) (166)
- Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. (2003) (166)
- Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements (2010) (153)
- Epidemiology and Surveillance of Hepatocellular Carcinoma (2012) (151)
- Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population (2014) (143)
- MRP2 haplotypes confer differential susceptibility to toxic liver injury (2007) (143)
- Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis (2008) (142)
- Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? (2009) (138)
- Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. (2015) (138)
- Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90 (2013) (135)
- Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean (2012) (135)
- Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir (2011) (134)
- MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. (2008) (134)
- Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study (2005) (127)
- Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B (2009) (126)
- Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection (2007) (118)
- Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. (2014) (117)
- Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis (2015) (116)
- Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. (2005) (115)
- Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy (2014) (114)
- Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia (2011) (113)
- Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B (2007) (110)
- Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3) (2008) (110)
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements (2020) (109)
- The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. (2012) (104)
- Repetitive short‐course hepatic arterial infusion chemotherapy with high‐dose 5‐fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma (2007) (104)
- Prediction of microvascular invasion before curative resection of hepatocellular carcinoma (2008) (103)
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Detecting Extrahepatic Metastasis in Pretreatment Staging of Hepatocellular Carcinoma (2007) (100)
- Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long‐term clinical outcomes of 1717 treatment‐naïve patients with hepatocellular carcinoma (2012) (100)
- Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. (2006) (100)
- New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA Quantification (2010) (99)
- Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation (2012) (98)
- Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis (2012) (95)
- How Can We Enhance the Performance of Liver Stiffness Measurement Using FibroScan in Diagnosing Liver Cirrhosis in Patients With Chronic Hepatitis B? (2010) (94)
- PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection (2007) (93)
- Autologous Bone Marrow Infusion Activates the Progenitor Cell Compartment in Patients with Advanced Liver Cirrhosis (2010) (93)
- Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy (2015) (92)
- Long‐term outcome of chronic hepatitis B based on histological grade and stage (2007) (91)
- A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea. (2019) (87)
- Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. (2009) (86)
- Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization (2005) (83)
- A nationwide seroepidemiology of hepatitis C virus infection in South Korea (2013) (83)
- Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography (2004) (82)
- Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2017) (82)
- Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography–defined subclinical cirrhosis (2015) (82)
- Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma (2006) (81)
- What are ‘true normal’ liver stiffness values using FibroScan®?: a prospective study in healthy living liver and kidney donors in South Korea (2010) (81)
- Serotonin signals through a gut-liver axis to regulate hepatic steatosis (2018) (80)
- Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients (2016) (78)
- Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot study (2008) (78)
- Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. (2016) (76)
- No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection. (2016) (76)
- Liver Cancer Working Group report. (2010) (72)
- Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid (2006) (72)
- Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients (2016) (71)
- Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. (2013) (71)
- Prediction of Recurrence after Curative Resection of Hepatocellular Carcinoma using Liver Stiffness Measurement (FibroScan®) (2012) (71)
- Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors (2008) (71)
- Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. (2003) (70)
- Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel (2014) (70)
- Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis (2009) (69)
- Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease (2015) (68)
- Application of surveillance programs for hepatocellular carcinoma in the Asia–Pacific Region (2009) (68)
- Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. (2017) (68)
- Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B (2013) (68)
- CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin‐10 in mice (2012) (67)
- Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study (2015) (67)
- Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B (2012) (65)
- Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment (2015) (64)
- Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model (2011) (64)
- Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B (2010) (62)
- Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial‐embolization prognostic score (2016) (62)
- Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease (2016) (62)
- Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. (2011) (62)
- Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. (2019) (61)
- Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region (2013) (61)
- Prognostic value of 18F‐FDG PET for hepatocellular carcinoma patients treated with sorafenib (2011) (60)
- Normal liver elasticity values using acoustic radiation force impulse imaging: A prospective study in healthy living liver and kidney donors (2012) (59)
- STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) (2014) (58)
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC) (2013) (58)
- Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study (2009) (57)
- The Accuracy of Noninvasive Methods in Predicting the Development of Hepatocellular Carcinoma and Hepatic Decompensation in Patients With Chronic Hepatitis B (2012) (57)
- A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma. (2020) (56)
- Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials (2016) (55)
- Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection (2011) (55)
- Applying a system approach to forecast the total hepatitis C virus‐infected population size: model validation using US data (2011) (55)
- Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status. (2017) (54)
- Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma (2009) (54)
- Characterization of focal liver masses using acoustic radiation force impulse elastography. (2013) (54)
- Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model (2008) (54)
- Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model (2016) (54)
- Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. (2003) (54)
- Early α‐fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma (2011) (54)
- Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma (2011) (53)
- New Diagnostic Method for Liver Fibrosis and Cirrhosis (2008) (53)
- Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection (2011) (53)
- 18F‐fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma (2011) (53)
- Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation (2012) (52)
- Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B (2012) (51)
- Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization (2013) (51)
- Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment (2015) (50)
- Clinical outcome of renal transplantation in patients with positive pre‐transplant hepatitis B surface antigen (2007) (49)
- A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma (2009) (49)
- Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke. (2017) (47)
- Efficacy of adefovir add‐on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine‐resistant chronic hepatitis B (2010) (47)
- Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitis (2009) (47)
- Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. (2009) (47)
- Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy (2014) (46)
- Comparison of Surrogate Serum Markers and Transient Elastography (Fibroscan) for Assessing Cirrhosis in Patients with Chronic Viral Hepatitis (2010) (45)
- Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study (2013) (45)
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk. (2020) (45)
- Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression (2010) (45)
- The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: A multicenter, prospective study (2011) (45)
- Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis (2005) (44)
- Natural history of hepatitis B virus–related cirrhotic patients hospitalized to control ascites (2008) (43)
- Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model (2013) (43)
- Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis (2017) (42)
- No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations (2012) (42)
- Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy (2010) (42)
- Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea (2006) (42)
- [Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry]. (2004) (42)
- Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries. (2020) (42)
- Number of Target Lesions for EASL and Modified RECIST to Predict Survivals in Hepatocellular Carcinoma Treated with Chemoembolization (2012) (41)
- Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine‐resistant disease (2010) (41)
- Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin (2015) (41)
- Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma (2015) (41)
- Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma (2014) (41)
- 69 NEPTUNE STUDY: ON-TREATMENT HBSAG LEVEL ANALYSIS CONFIRMS PREDICTION OF RESPONSE OBSERVED IN PHASE 3 STUDY OF PEGINTERFERON ALFA-2A IN HBEAG-POSITIVE PATIENTS (2011) (40)
- Effects of Virologic Response to Treatment on Short‐ and Long‐term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis (2018) (40)
- Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate (2012) (40)
- Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea. (2012) (39)
- Issues and controversies of hepatocellular carcinoma‐targeted therapy clinical trials in Asia: experts' opinion (2010) (39)
- A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma (2010) (39)
- Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update (2012) (39)
- Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma (2016) (38)
- Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg‐negative carriers (2012) (38)
- Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection (2009) (38)
- Predictive factors for long‐term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma (2011) (38)
- Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis (2015) (38)
- Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2019) (37)
- Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma (2014) (37)
- Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy (2003) (37)
- Impact of Spontaneous Hepatocellular Carcinoma Rupture on Recurrence Pattern and Long-term Surgical Outcomes after Partial Hepatectomy (2014) (36)
- Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study (2015) (36)
- Role of surgical resection for multiple hepatocellular carcinomas. (2013) (36)
- Emerging Therapies for Hepatitis C (2014) (36)
- Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection. (2019) (36)
- Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test (2014) (36)
- Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels (2012) (36)
- Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population‐based nationwide study (2008) (36)
- Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease (2014) (36)
- Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B. (2016) (35)
- Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation (2013) (34)
- Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy (2016) (34)
- Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats (2011) (34)
- Ascitic fluid infection in patients with hepatitis B virus‐related liver cirrhosis: Culture‐negative neutrocytic ascites versus spontaneous bacterial peritonitis (2010) (34)
- Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. (2019) (34)
- Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea (2017) (34)
- Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality (2016) (34)
- Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase (2020) (33)
- Ascites and spontaneous bacterial peritonitis: An Asian perspective (2009) (33)
- The Clinical Impact of Early Detection of the Ymdd Mutant on the Outcomes of Long-Term Lamivudine Therapy in Patients with Chronic Hepatitis B (2005) (33)
- Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir (2017) (33)
- Hepatic Splenosis Preoperatively Diagnosed as Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B: A Case Report (2008) (33)
- Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. (2011) (33)
- “Normal” liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population (2012) (33)
- Long‐term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir (2014) (33)
- Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. (2007) (33)
- Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial (2018) (33)
- Clinical Features and Treatment Outcomes of Upper Gastrointestinal Bleeding in Patients with Cirrhosis (2008) (33)
- Molecular and clinical characteristics of hepatitis B virus in Korea (2010) (33)
- New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia (2014) (33)
- Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions. (2014) (33)
- Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016 (2016) (32)
- Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients (2019) (32)
- Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018) (32)
- Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection (2009) (32)
- Factors associated with significant liver fibrosis assessed using transient elastography in general population. (2015) (32)
- Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging (2013) (31)
- Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection (2013) (31)
- Surgical resection for pulmonary metastasis from hepatocellular carcinoma: Analysis of prognosis in relation to primary control (2010) (31)
- Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer (2017) (31)
- A novel liver stiffness measurement‐based prediction model for cirrhosis in hepatitis B patients (2010) (31)
- Combined measurement of preoperative α‐fetoprotein and des‐γ‐carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis‐B‐related hepatocellular carcinoma (2012) (30)
- Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus (2016) (30)
- A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography (2015) (30)
- Red cell volume distribution width‐to‐platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B (2016) (30)
- Transient elastography in chronic hepatitis B: an Asian perspective. (2010) (30)
- Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma. (2019) (30)
- Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. (2009) (29)
- Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development (2017) (29)
- The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter (2016) (29)
- Long‐term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study (2005) (29)
- Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model (2014) (28)
- Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis (2012) (28)
- Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea (2011) (28)
- Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study (2020) (28)
- Chemotherapy for advanced hepatocellular carcinoma (2008) (28)
- Rescue Monotherapy in Lamivudine-Resistant Hepatitis B e Antigen-Positive Chronic Hepatitis B: Adefovir versus Entecavir (2008) (28)
- Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma (2013) (28)
- Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions (2014) (28)
- Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. (2011) (28)
- [Association between CCR5 promoter polymorphisms and hepatitis B virus infection]. (2005) (27)
- High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway (2019) (27)
- Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first‐line therapy: A Korean multicenter study (2014) (27)
- Clinical usefulness of double biomarkers AFP and PIVKA‐II for subdividing prognostic groups in locally advanced hepatocellular carcinoma (2014) (27)
- External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy (2019) (27)
- Predictive Value of Liver Cell Dysplasia for Development of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B (2008) (27)
- Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. (2007) (27)
- Preoperative Radiologic and Postoperative Pathologic Risk Factors for Early Intra-Hepatic Recurrence in Hepatocellular Carcinoma Patients Who Underwent Curative Resection (2009) (26)
- A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea (2019) (26)
- The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis (2015) (26)
- Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy (2016) (26)
- Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir (2018) (26)
- The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size (2009) (26)
- Entecavir plus tenofovir combination therapy in patients with multidrug‐resistant chronic hepatitis B: results of a multicentre, prospective study (2016) (26)
- Early on‐treatment predictions of clinical outcomes using alpha‐fetoprotein and des‐gamma‐carboxy prothrombin responses in patients with advanced hepatocellular carcinoma (2012) (26)
- Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data (2016) (26)
- Liver cancer in Korea (2007) (25)
- Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response (2015) (25)
- Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir (2014) (25)
- Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma (2014) (25)
- Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis (2016) (25)
- Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker (2014) (25)
- Early on‐treatment change in liver stiffness predicts development of liver‐related events in chronic hepatitis B patients receiving antiviral therapy (2013) (24)
- Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan®) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment (2013) (24)
- [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. (2008) (24)
- Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. (2015) (24)
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver ⇑ , Asociación Latinoamericana para el Estudio del Hígado (2015) (24)
- Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma (2015) (24)
- A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea (2019) (23)
- Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study (2017) (23)
- A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus (2016) (23)
- Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification (2015) (23)
- Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. (2003) (23)
- Validation of the CAMD score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy. (2020) (23)
- How to Predict HCC Development in Patients with Chronic B Viral Liver Disease? (2005) (22)
- Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement (2012) (22)
- Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study (2021) (22)
- Treatment of non‐resectable hepatocellular carcinoma (2002) (22)
- Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis (2017) (22)
- Partial Virological Response to Entecavir in Treatment-Naive Patients with Chronic Hepatitis B (2011) (22)
- A multicenter, open-label, phase 3 trial to compare the efficacy and safety of lenvatinib (E7080) versus sorafenib in first-line treatment of subjects with unresectable hepatocellular carcinoma. (2014) (21)
- Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis (2017) (21)
- Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma (2011) (21)
- Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B (2015) (21)
- The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter (2017) (21)
- Hepatitis C Virus and Antiviral Drug Resistance (2016) (21)
- Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma. (2011) (21)
- Inhibition of tumour angiogenesis and growth by small hairpin HIF‐1α and IL‐8 in hepatocellular carcinoma (2014) (21)
- Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy (2013) (21)
- Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma. (2019) (20)
- Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon‐α therapy (1996) (20)
- Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization (2015) (20)
- Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study (2020) (20)
- Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus‐related advanced fibrosis or cirrhosis (2018) (20)
- Identifying and prioritizing strategies for comprehensive liver cancer control in Asia (2011) (20)
- Long-term Entecavir Therapy Results in Reversal of Fibrosis/Cirrhosis and Continued Histologic Improvement in Patients with HBeAg(+) and (-) Chronic Hepatitis B: Results from Studies ETV-022, -027 and -901 (2008) (20)
- Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy (2016) (20)
- How to Improve Treatment Outcomes for Hepatocellular Carcinoma of Intermediate and Advanced Stage (2012) (20)
- Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B (2018) (20)
- Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis. (2003) (20)
- Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography (2015) (20)
- The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. (2010) (20)
- Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation (2019) (19)
- Hepatitis B e antigen‐negative mutations in the precore and core promoter regions in Korean patients (2009) (19)
- Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway (2017) (19)
- Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib (2015) (19)
- Reimbursement policies in the Asia-Pacific for chronic hepatitis B (2014) (19)
- Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation (2017) (19)
- Variability in liver stiffness values from different intercostal spaces (2009) (19)
- Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus‐related advanced hepatocellular carcinoma (2012) (19)
- Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database (2016) (19)
- Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years (2014) (19)
- Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea (2007) (19)
- Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B (2015) (19)
- Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background (2016) (19)
- Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma (2013) (18)
- The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C (2018) (18)
- Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study (2010) (18)
- Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? (2010) (18)
- Antibody-Secreting Cells with a Phenotype of Ki-67low, CD138high, CD31high, and CD38high Secrete Nonspecific IgM during Primary Hepatitis A Virus Infection (2013) (18)
- Early Predictor of Mortality due to Irreversible Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma (2013) (18)
- Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B (2019) (18)
- [Protein expression profiles in a rat cirrhotic model induced by thioacetamide]. (2006) (18)
- Comparison of Hepatic Venous Pressure Gradient and Two Models of End-stage Liver Disease for Predicting the Survival in Patients With Decompensated Liver Cirrhosis (2012) (18)
- Current Situation of Hepatocellular Carcinoma in Mongolia (2011) (18)
- Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination. (2015) (18)
- Diffusion and perfusion MRI prediction of progression‐free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy (2014) (17)
- The significance of ICG‐R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma (2012) (17)
- Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection (2019) (17)
- Long‐term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea (2014) (17)
- Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy (2020) (17)
- Bacterial cell surface display for epitope mapping of hepatitis C virus core antigen. (2003) (17)
- Combination therapy of thymosin alpha‐1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study (2008) (17)
- [Clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus]. (2007) (17)
- Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity (2004) (17)
- Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice (2014) (17)
- Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma (2014) (17)
- Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib (2015) (16)
- Effect of S267F variant of NTCP on the patients with chronic hepatitis B (2017) (16)
- Treatment of recurrent hepatocellular carcinoma after liver transplantation (2011) (16)
- Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease (2016) (16)
- Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection (2018) (16)
- Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea (2016) (16)
- Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals (2019) (16)
- Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. (2014) (16)
- Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease (2017) (16)
- Positioning and Indication of Sorafenib in the Treatment Algorithm and Real Practice Setting: Western and Eastern Approach – Asian Perspective (2010) (16)
- What is the role of diagnostic laparoscopy in a gastroenterology unit? (2007) (16)
- Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa). (2004) (16)
- Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B‐viral cirrhosis (2010) (16)
- Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in Korea (2014) (16)
- Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort (2014) (16)
- Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells (2015) (15)
- Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals (2019) (15)
- Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease (2014) (15)
- Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer. (2017) (15)
- Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check‐up and in living liver donors in South Korea (2013) (15)
- Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial (2020) (15)
- Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. (2010) (15)
- Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B (2016) (15)
- The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization (2020) (15)
- Efficacy and safety of liver-directed concurrent chemoradiotherapy and sequential sorafenib for advanced hepatocellular carcinoma; a prospective phase 2 trial. (2020) (15)
- Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (15)
- Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B (2013) (15)
- A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma (2015) (15)
- Combination of preS Deletions and A1762T/G1764A Mutations in HBV Subgenotype C2 Increases the Risk of Developing HCC (2011) (14)
- Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma (2014) (14)
- Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack (2020) (14)
- Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines (2010) (14)
- Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean Patients with hepatocellular carcinoma (Journal of Medical Virology (2009) 81, (1002-1008)) (2009) (14)
- Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B (2013) (14)
- Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma. (2019) (14)
- Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib (2018) (14)
- A case of embryonal sarcoma of the liver mimicking a hydatid cyst in an adult. (2010) (14)
- Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase (2020) (14)
- Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats. (2010) (14)
- How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan® in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements (2012) (14)
- Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B (2020) (14)
- Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy (2011) (13)
- HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI‐Resistance associated substitutions in HCV‐Infected patients in Mainland China (2018) (13)
- Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (2015) (13)
- Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions (2012) (13)
- Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. (2014) (13)
- Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study (2012) (13)
- Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection. (2019) (13)
- Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. (2011) (13)
- Safety of peginterferon alfa‐2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients (2012) (13)
- Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study (2019) (13)
- Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma (2017) (13)
- Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. (2017) (13)
- Clinical Application of Liver Stiffness Measurement Using Transient Elastography: A Surgical Perspective (2013) (13)
- Optimal Time for Restoring the Reliability of Liver Stiffness Measurement in Patients With Chronic Hepatitis B Experiencing Acute Exacerbation (2012) (13)
- Silencing of Hypoxia-Inducible Factor-1β Induces Anti-Tumor Effects in Hepatoma Cell Lines under Tumor Hypoxia (2014) (13)
- Non‐invasive assessment of liver fibrosis: Time to move from cross‐sectional studies to longitudinal ones (2010) (13)
- Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial (2012) (13)
- Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT. (2011) (12)
- Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response (2016) (12)
- Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis (2019) (12)
- Treatment of Chronic Hepatitis B in Asia-Pacific Countries: Is the Asia-Pacific Consensus Statement being followed? (2010) (12)
- Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease (2014) (12)
- Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B (2013) (12)
- A 96-Week Randomized Trial of Switching to Entecavir in Chronic Hepatitis B Patients with a Partial Virological Response to Lamivudine (2012) (12)
- Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats (2013) (12)
- Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus (2020) (12)
- Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries (2014) (12)
- The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus‐related hepatocellular carcinoma (2009) (12)
- Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy. (2012) (12)
- Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection. (2002) (12)
- Assessment of the Efficacy of Reducing Peginterferon Alfa-2a and Ribavirin Dose on Virologic Response in Koreans with Chronic Hepatitis C (2009) (11)
- Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis (2017) (11)
- Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers (2014) (11)
- Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B (2013) (11)
- Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B (2015) (11)
- Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma (2013) (11)
- [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model]. (2008) (11)
- [Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]. (2010) (11)
- Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status (2019) (11)
- Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection. (2019) (10)
- Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the milan criteria. (2020) (10)
- Long-Term Follow-Up of Patients after Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis (2017) (10)
- External Validation of P2/MS and Comparison with Other Simple Non-invasive Indices for Predicting Liver Fibrosis in HBV-Infected Patients (2010) (10)
- Maintaining remission in lamivudine‐resistant patients with a virological response to adefovir add‐on lamivudine after stopping lamivudine therapy (2014) (10)
- Outcome of adefovir add‐on lamivudine rescue therapy of up to 5 years in patients with lamivudine‐resistant chronic hepatitis B (2016) (10)
- Clinical Course of Virologic Breakthrough after Emergence of YMDD Mutations in HBeAg-Positive Chronic Hepatitis B (2008) (10)
- An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys) (2016) (10)
- Transgenic mouse model expressing P53R172H, luciferase, EGFP, and KRASG12D in a single open reading frame for live imaging of tumor (2015) (10)
- Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma (2019) (9)
- Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial (2021) (9)
- Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma (2020) (9)
- Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma (2013) (9)
- Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma (2019) (9)
- Improvement in liver histology among Asian patients with chronic hepatitis B after long‐term treatment with entecavir (2013) (9)
- Analysis of miRNA expression patterns in human and mouse hepatocellular carcinoma cells (2015) (9)
- Non-invasive assessment of liver fibrosis by measuring the liver stiffness and biochemical markers in chronic hepatitis B patients (2007) (9)
- High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice (2013) (8)
- Immunogenetics of hepatitis B virus infection (2002) (8)
- Clinical features and prognosis of hepatocellular carcinoma with respect to pre‐S deletion and basal core promoter mutations of hepatitis B virus Genotype C2 (2011) (8)
- Pre‐S mutations of hepatitis B virus affect genome replication and expression of surface antigens (2014) (8)
- Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance (2018) (8)
- Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety (2018) (8)
- Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion (2020) (8)
- Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B (2017) (8)
- Multicenter prospective randomized controlled trial comparing propranolol, endoscopic band ligation, and combination therapy for the primary prophylaxis variceal bleeding in patients with liver cirrhosis (2017) (8)
- Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study) (2016) (8)
- The Efficacy of Endoscopic Palliation of Obstructive Jaundice in Hepatocellular Carcinoma (2014) (8)
- Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study (2012) (8)
- Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis (2019) (8)
- Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C (2016) (8)
- Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy (2010) (8)
- [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection]. (2002) (8)
- Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C. (2020) (8)
- Lamivudine plus adefovir vs. entecavir in HBeAg‐positive hepatitis B with sequential treatment failure of lamivudine and adefovir (2012) (8)
- Prediction of virologic response to tenofovir mono‐rescue therapy for multidrug resistant chronic hepatitis B (2016) (7)
- Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis (2014) (7)
- Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis (2019) (7)
- Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S) (2014) (7)
- [Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report]. (2009) (7)
- Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. (2012) (7)
- Final Results of Open-Label Treatment with Eltrombopag During ENABLE 1: A Study of Eltrombopag As An Adjunct for Antiviral Treatment of Hepatitis C Virus Associated with Thrombocytopenia (2011) (7)
- An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate (2020) (7)
- Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy (2017) (7)
- Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. (2019) (7)
- Long-Term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection. (2019) (7)
- [Concurrent chemo-radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis]. (2002) (7)
- Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. (2010) (7)
- A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea (2020) (7)
- Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus (2014) (6)
- Clinical predictors of silent but substantial liver fibrosis in primary Sjogren’s syndrome (2016) (6)
- Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma (2020) (6)
- 741 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study (2006) (6)
- Association Between Polymorphism of Tumor Necrosis Factor-α Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B (2010) (6)
- Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection (2019) (6)
- Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization (2017) (6)
- Recombinant interferon-Beta-1alpha plus ribavirin for the treatment of chronic HCV infection: a prospective, randomized, comparative pilot study. (2009) (6)
- Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea (2006) (6)
- [Clinical features and prognostic factors of fulminant hepatic failure in Koreans]. (2004) (6)
- Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT (2021) (6)
- Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database (2019) (6)
- Gamma-Glutamyl Transpeptidase-to-Platelet Ratio is an Independent Predictor of Hepatitis B Virus-Related Liver Cancer (2016) (6)
- [Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases]. (2008) (6)
- Non‐invasive assessment of liver fibrosis: The gap between ideal and real (2011) (6)
- Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis. (2012) (6)
- HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study (2018) (5)
- Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy (2010) (5)
- [A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma]. (2011) (5)
- HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines (2020) (5)
- Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update? (2018) (5)
- Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection (2017) (5)
- The Usefulness and Current Status of the Screening Program for Early Diagnosis of Hepatocellular Carcinoma (2002) (5)
- Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy (2017) (5)
- [Clinical efficacy of serum PIVKA-II in the diagnosis and follow up after treatment of hepatocellular carcinoma]. (2002) (5)
- Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir. (2013) (5)
- Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma (2015) (5)
- Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization. (2015) (5)
- Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma (2019) (5)
- Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma (2010) (5)
- Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B (2020) (5)
- [Reappraisal of risk factors predicting liver complications from radiotherapy for hepatocellular carcinoma]. (2006) (5)
- Non-O1, Non-O139 Vibrio cholerae Septicemia after Acupuncture (2013) (5)
- Safety and efficacy of besifovir in treatment-naïve chronic hepatitis B virus infection: a randomized, double-blind, double dummy, phase 3 study (2017) (5)
- Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers (2018) (5)
- Multimodality Treatment with Radiotherapy for Huge Hepatocellular Carcinoma (2014) (5)
- Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha‐foetoprotein and 18F‐fluoro‐2‐deoxyglucose positron emission tomography (2017) (5)
- Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation (2017) (5)
- Prediction of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis Using the P2/MS Noninvasive Index Based on Complete Blood Counts (2012) (4)
- Characteristics and Survival of Korean Patients with Hepatocellular Carcinoma: A Nationwide Random Sample Study (2014) (4)
- Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study (2006) (4)
- The Efficacy of the Ultrasonographic Screening Test for Early Detection of Hepatocellular Carcinoma and Risk Factors of HCC in Korea (2000) (4)
- [Changes of ascites nitric oxide according to the treatment course in cirrhotic patients with spontaneous bacterial peritonitis]. (2004) (4)
- Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation (2012) (4)
- Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma (2020) (4)
- The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years (2019) (4)
- The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses (2020) (4)
- Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen‐positive chronic hepatitis B patients (2014) (4)
- Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. (2020) (4)
- Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of Snail (2017) (4)
- P0809 : 98% SVR12 in Korean And Taiwanese patients with chronic genotype 2 HCV infection receiving 12 weeks of sofosbuvir plus ribavirin: Results from an international, multicenter phase 3 study (2015) (4)
- Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis. (2015) (4)
- Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B. (2020) (4)
- Cell culture‐adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes (2017) (4)
- [Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis]. (2005) (4)
- Clinical characteristics of acute hepatitis A complicated by acute kidney injury (2012) (4)
- Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma (2007) (3)
- Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B (2011) (3)
- A proposal for the developing plan of the Korean Association of Internal Medicine (2008) (3)
- A 96‐week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy (2016) (3)
- Treatment of Hepatocellular Carcinoma With Lenvatinib. (2018) (3)
- The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma (2016) (3)
- Radiological–pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery (2016) (3)
- Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B (2013) (3)
- Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis (2019) (3)
- Transitional features of histologic type of non‐alcoholic fatty liver disease in Korean young men (2012) (3)
- Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C. (2020) (3)
- Tenofovir Mono-rescue Therapy vs. Tenofovir Plus Entecavir Combination-rescue Therapy in Chronic Hepatitis B with Lamivudine and Entecavir Resistance (2014) (3)
- Single Center Experience (Ten Years) with Surgical Resection for Treating Hepatocellular Carcinoma - Strategies for improving the long-term survival after resection (2008) (3)
- Risk factors of acute hepatic failure associated with transcatheter arterial chemoembolization for hepatocellular carcinoma (2005) (3)
- Comparison of efficacy of cefotaxime, ceftriaxone, and ciprofloxacin for the treatment of spontaneous bacterial peritonitis in patients with liver cirrhosis: a randomized controlled trial (2017) (3)
- Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma (2021) (3)
- Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B (2011) (3)
- [Radiation therapy for bone metastasis from hepatocellular carcinoma]. (2002) (3)
- Epidemiological and Clinical History of Viral Hepatitis in Korea (2021) (3)
- Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B. (2020) (2)
- Four-Year Treatment with Entecavir Results in High Proportions of Nucleoside-Naïve HBeAg-Positive Patients with Undetectable HBV DNA: Results from Studies ETV-022 and -901 (2008) (2)
- Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model (2019) (2)
- hTERT promoter gene polymorphism and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (초) (2010) (2)
- 759 IMPACT OF ENTECAVIR VERSUS LAMIVUDINE ON HEPATIC COVALENTLY CLOSED-CIRCULAR DNA AND TOTAL HEPATIC HBVDNA IN NUCLEOSIDE-NAÏVE HBeAg POSITIVE CHRONIC HEPATITIS B PATIENTS (2013) (2)
- [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study]. (2002) (2)
- HBeAg Seroconversion Rates after Five Years of Follow-Up in Patients Treated with Peginterferon Alfa-2a (40kd) in Neptune: Final Results of the Son of Neptune Long-Term Follow-Up Study (2016) (2)
- Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model (2016) (2)
- [HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy]. (2005) (2)
- 320 Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs (2009) (2)
- Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC): Data from HCC registry in Asia. (2019) (2)
- The 4th Asia-Pacific Primary Liver Cancer Expert Meeting (2013) (2)
- [Natural history of HBeAg negative chronic hepatitis B virus infection: a cohort study]. (2006) (2)
- Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection: The Impact of Treatment and Sustained Virologic Response (SVR) (2017) (2)
- [Clinical outcome of pulmonary resections in patients with pulmonary metastasis of hepatocellular carcinoma]. (2005) (2)
- Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis. (2019) (2)
- A Prospective Randomized Trial of Switching to Telbivudine Plus Adefovir in HBeAg-positive Lamivudine-resistant Chronic Hepatitis B Patients Who Have Suboptimal Response to Lamivudine Plus Adefovir (2014) (2)
- High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis (2020) (2)
- Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B (2013) (2)
- [A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C]. (2009) (2)
- Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization (2019) (2)
- Hepatitis C Virus Attenuates Interferon-Induced MHC Class I Expression and Decreases CD 8 + T-Cell Effector Functions (2015) (2)
- Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy (2019) (2)
- Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia (2019) (2)
- Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study (2020) (2)
- Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy (2015) (2)
- Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (2)
- Continuing Besifovir Dipivoxil Maleate versus switching from Tenofovir Disoproxil Fumarate for treatment of chronic hepatitis B: 96 weeks results of phase 3 trial (2018) (2)
- Radiotherapy results of unresectable hepatocellular carcinoma; A retrospective study of 158 patients (2003) (2)
- The Risk Factors for the Intrahepatic Recurrence of Hepatocellular Carcinoma after Curative Resection (2008) (1)
- [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B]. (2002) (1)
- The effect of preoperative transcatheter hepatic arterial chemoembolization in the treatment of hepatocellular carcinoma (2006) (1)
- Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials (2021) (1)
- Reimbursement policies in Asia-Pacific for chronic Hepatitis B (2009) (1)
- The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine (2016) (1)
- 946 Association between CCR5 promoter polymorphism and hepatitis B virus infection (2003) (1)
- Applications of molecular barcode sequencing for the detection of low‐frequency variants in circulating tumour DNA from hepatocellular carcinoma (2022) (1)
- Correction to: Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase. (2020) (1)
- Chemoembolization Survivals in Hepatocellular Carcinoma Treated with Number of Target Lesions for EASL and Modified RECIST to Predict (2013) (1)
- 1115 Risk factors for hepatocellular carcinoma in hepatitis B surface antigen positive carriers (2003) (1)
- Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study (2020) (1)
- Entecavirandtenofoviron renal function in patients with hepatitis B virus related hepatocellular carcinoma. (2020) (1)
- Hepatitis B viral load to predict survival of HCC patients treated with sorafenib. (2014) (1)
- M1907 Efficacy of Entecavir in Nucleoside-NaïVe Patients with Mildly Elevated ALT (2008) (1)
- Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study (2019) (1)
- [A case of hepatic congestion due to right heart failure mimicking liver tumor]. (2010) (1)
- Long-term entecavir (ETV) therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg positive and negative chronic hepatitis B (CHB): results from studies ETV-022,-027 and-901 (2009) (1)
- Usefulness of PIVKA-II for diagnosis and evaluation of recurrence of hepatocellular carcinoma (2005) (1)
- Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study (2019) (1)
- PREDICTORS OF PREMATURE WITHDRAWAL AND DOSE REDUCTIONS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A (40KD) (PEGIFN alpha 2A) PLUS RIBAVIRIN IN A LARGE, MULTINATIONAL, OPEN-LABEL EXPANDED ACCESS PROGRAM (2009) (1)
- Independent imaging review (IIR) results in a phase 3 trial of lenvatinib (LEN) versus sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2018) (1)
- [A case of successful endoscopic clipping for iatrogenic colon perforation induced by peritoneal catheter insertion]. (2014) (1)
- Impact of hepatic steatosis and controlled attenuation parameter (CAP) on accuracy of fibrosis staging using transient elastography (2017) (1)
- Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization (2013) (1)
- 633 Histologic Improvement in Asian Patients With HBeAg(+) and HBeAg(−) Chronic Hepatitis B After Long-Term Treatment With Entecavir: Results From ETV-022, -027 and -901 Studies (2010) (1)
- Noninvasive Predictive Model for Detection of High-risk Esophageal Varices in B-viral Liver Cirrhosis (2014) (1)
- Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma? (2011) (1)
- Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial (2023) (1)
- 959 Comparison of histological and clinical changes between before and after spontaneous loss of hepatitis B surface antigen (2003) (1)
- Long-term entecavir therapy improves fibrosis/cirrhosis and results in continued histologic improvement in CHB (2009) (1)
- Cost-Effectiveness Modeling Study of boceprevir for the treatment of patients with genotype 1 chronic hepatitis C virus infection in Hong Kong (2013) (1)
- Direct-acting antivirals improve treatment outcomes in patients with chronic hepatitis C-related hepatocellular carcinoma treated with transarterial chemoembolization: a nationwide, multi-center, retrospective cohort study (2020) (0)
- Correction (2012) (0)
- Clinical Characteristics of Hepatocellular Carcinoma in Young People (2000) (0)
- Chronic Liver Failure Management: Management of Bacterial Infections (2011) (0)
- HCC : PE-054 ; Prospective comparison of prognostic values of modified recist with EASL criteria in hepatocellular carcinoma following chemoembolization (2012) (0)
- 747 A 96-WEEK RANDOMIZED TRIAL OF SWITCHING TO ENTECAVIR IN CHRONIC HEPATITIS B PATIENTS WITH A COMPLETE VIROLOGIC RESPONSE TO LAMIVUDINE (2013) (0)
- Subject Index Vol. 81, Suppl. 1, 2011 (2011) (0)
- Impact of a shortened surveillance interval on hepatocellular carcinoma survival. (2014) (0)
- FRI-179-Antiviral therapy might not be required for chronic hepatitis B patients in the immune-tolerant phase with a significantly low incidence rate of liver-related events (2019) (0)
- Non-invasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients with Hepatitis B Virus Infection (2006) (0)
- [Free Paper] The risk-adjusted follow-up intervals after curative resection of hepatocellular carcinoma (2011) (0)
- Clinical characteristics and prognosis of hepatocellular carcinoma with Lower serum values of AFP and PIVKA-2 (2009) (0)
- The APPLE Association President's Message (2017) (0)
- Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis (2019) (0)
- Two cases of Vessel invasion of Hepatocellular carcinoma (2007) (0)
- Predictive factors for long-term survival in patients with portal hypertension following resection of hepatocellular carcinoma (2010) (0)
- Author Correction: Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals (2019) (0)
- P444 PREDICTION OF ESOPHAGEAL VARICES USING ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY IN CIRRHOTIC PATIENTS: DEVELOPMENT AND VALIDATION OF A NOVEL PREDICTIVE MODEL (KOREAN MULTI-CENTER STUDY) (2014) (0)
- Subclassification of Hepatocellular Carcinoma with Barcelona Clinic Liver Cancer Intermediate Stage (2016) (0)
- The Prognostic Significance of the Worst Grade in Hepatocellular Carcinoma with Mixed Histologic Grades (2012) (0)
- Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Cirrhotic Patients (2017) (0)
- Liver-Directed Multi-Modality Therapy As A Down-Staging Strategy For Locally Advanced Hepatocellular Carcinoma Beyond The Milan Criteria (2020) (0)
- FRI-458-Response evaluation using modified RECIST criteria predict outcomes better than RECIST 1.1 criteria in patients with HCC treated with Yttrium-90 radioembolization (2019) (0)
- Transforming Growth Factor Beta Promotes Liver Tumorigenesis in Mice via Upregulation of Snail ( Short title : TGF-β tumor promotion through an EMT inducer ) (2017) (0)
- The prevalence of 25(OH)D3 in the patients of South China with chronic HBV infection and high 25(OH)D3 related with low HBV DNA viral load (2014) (0)
- A Case of Recurred Hepatocellular Carcinoma after Treated by Trans-Arterial Chemoembolization (2014) (0)
- Significance of ICG-R15 in Predicting Hepatic Toxicity in Patients Receiving Radiotherapy for Hepatocellular Carcinoma (2010) (0)
- A Case of Advanced Hepatocellular Carcinoma with Inferior Vena Caval Invasion, Resected with a Curative Aim after Concurrent Chemo-Radiation Therapy (2007) (0)
- A study on the updating of prediction model for the development of hepatoma (2010) (0)
- Prediction of the Presence of Erosive Esophagitis Using Controlled Attenuation Parameter by Transient Elastography (2014) (0)
- Histological subclassification of cirrhosis can predict recurrence after (2014) (0)
- FRI-487-A new prognosis prediction model in patients with hepatocellular carcinoma after Yttrium-90 radioembolization (2019) (0)
- M1568 Anti-Fibrogenic Effects of Lithospermate B in Human Hepatic Stellate Cells and Thioacetamide-Induced Cirrhotic Rats (2008) (0)
- Recombinant Interferon-beta-1a Plus Ribavirin in the Treatment of Chronic Hepatitis C: A Prospective, Randomised, Comparative Pilot Study (2005) (0)
- Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. (2016) (0)
- Early radiotherapy versus late radiotherapy after incomplete transarterial chemoembolization in hepatocellular carcinoma. (2015) (0)
- Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions (2014) (0)
- Evolution of hepatic fibrosis and steatosis during long-term use of metformin in patients with type 2 diabetes (2020) (0)
- Intrahepatic HBV-DNA of the patients with HBs seroclearance by lamivudine (2006) (0)
- Effect of S267F variant of NTCP on the patients with chronic hepatitis B (2017) (0)
- A Case of Positive Tumor Marker Response after Intra-arterial Deferoxamine Infusion Therapy in a Hepatocellular Carcinoma Patient with Decompensated Liver Function (2014) (0)
- FRI-488-Prognostic value of tumor markers after a complete response to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma following curative resection (2019) (0)
- Erratum: Clinical features and prognosis of hepatocellular carcinoma with respect to pre‐S deletion and basal core promoter mutations of hepatitis B virus Genotype C2 (2012) (0)
- HCC : The Role of Localized Concurrent Chemoradiotherapy in Huge (>10 cm) Hepatocellular Carcinoma (2013) (0)
- FRI-215-Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: 144 weeks results of phase 3 trial (2019) (0)
- A case of hepatocellular carcinoma confirmed histologically in primary biliary cirrhosis (2008) (0)
- [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector]. (2002) (0)
- Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea (2020) (0)
- Free Paper Session : LC & Liver Fibrosis ; Long term follow-up results of autologous bone marrow cell infusion in patients with advanced Liver cirrhosis (초) (2011) (0)
- Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats (2013) (0)
- Clinical Implication of Automatically Analysed AFP-L3 and PIVKA-II in the Diagnosis of Hepatocellular Carcinoma (2001) (0)
- F-FDG Uptake 18 Carcinoma and Intrahepatic Mass-Forming Cholangiocarcinoma with Increased Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular (2005) (0)
- Degree of Hepatic Fibrosis Assessed Using Transient Elastography is Independently Related with Coronary Artery Calcification in Nonalcoholic Liver Disease (2014) (0)
- A Case of Successful Treatment for Recurrent Hepatocellular Carcinoma with Long term Survival (2006) (0)
- Effect of Transplanted Bone Marrow Cells in Mice Model with Carbon Tetrachloride Induced Liver Fibrosis (2007) (0)
- Long-term therapeutic effects of partial splenic embolization on secondary hypersplenism (2007) (0)
- HCV Activates Protein Kinase R and Attenuates Interferon-Induced MHC Class I Expression to Circumvent CD8+ T-Cell Responses (2015) (0)
- Forum 第6回日本肝がん分子標的治療研究会ランチョンセミナー How to manage intermediate and advanced stage of HCC in the era of targeted therapy (2012) (0)
- Effect of the Reversion of NS5A S2204I Mutation on the Replication of Hepatitis C Virus (2014) (0)
- Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients (2021) (0)
- Subclassification of Hepatocellular Carcinoma with BCLC Intermediate (2016) (0)
- Hepatitis B : Clonal evolution of hepatitis B virus resistant to Lamivudine, adefovir and entecavir during therapy with Lamivudine and adefovir (초) (2011) (0)
- Sofosbuvir-based all-oral regimens for patients with chronic hepatitis C genotype 2 infection: integrated analysis of eleven clinical studies (2017) (0)
- Free Paper Session III (2006) (0)
- A Case of Necrotizing Pancreatitis after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (2012) (0)
- Efficacy of Tenofovir Mono-rescue Therapy in Chronic Hepatitis B Patients with Partial Viral Response to Previous Treatment (2014) (0)
- Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injectionwith Holmium-166 / Chitosan Complex ( Milican ) for the Treatment of Small Hepatocellular Carcinoma (2006) (0)
- Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis (2017) (0)
- [Immunization effect on Naegleria fowleri infection in splenectomized mice] (1988) (0)
- The assessment of liver fibrosis stage by two-dimensional shear wave ultrasound and Transient Elastography in patients with chronic liver disease (2017) (0)
- THU-225-Risk prediction model for hepatocellular carcinoma after hepatitis b e antigen seroclearance in patients treated with entecavir or tenofovir (2019) (0)
- The APPLE Association President's Message (2018) (0)
- The effect of additional local radiotherapy after transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma (2004) (0)
- A Case of Hepatocellular Carcinoma in Young Age Younger than 20 Years Old (2009) (0)
- The Diagnostic Accuracy of Red Cell Distribution Width-to-platelet Ratio in Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B (2014) (0)
- Two cases of sarcomatoid carcinoma of the liver associated with glomerulonephritis (2009) (0)
- THU-224-Validation of modified PAGE B in patients with chronic hepatitis B undergoing antiviral treatment (2019) (0)
- Percutaneous intratumoral injection of holmium-166 microaggregate for the treatment of small hepatocellular carcinoma (1995) (0)
- Reply (2016) (0)
- A Delayed Hepatico-colonic Fistula after Radiofrequency Ablation in Hepatocellular Carcinoma (2014) (0)
- Salvage Resection after Localized Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma (2012) (0)
- THU-209-Dynamics of a transient elastography-based risk prediction model for hepatocellular carcinoma treated with antiviral therapy in chronic hepatitis B: A multi-center retrospective cohort study from the Korean Transient Elastography Study Group (2019) (0)
- Association between various status of hepatitis B virus infection and HLA DRB1∗13/TNF-alpha promoter polymorphism in Korea (2002) (0)
- 738 HIGHEST RATES OF RESPONSE AT WEEK 72 OF THE NEPTUNE STUDY ARE ACHIEVED WITH PEGINTERFERON ALFA-2A 180 μG FOR 48 WEEKS (2011) (0)
- 970 Molecular characterization of hepatitis B virus surface antigen negativity caused by spontaneous loss or antiviral therapy (2003) (0)
- Dickkopf-1 enhances tumourigenic potential by inducing liver angiogenesis (2020) (0)
- New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA Quantification (cid:1) † (2010) (0)
- Acute hepatitis A, B and C but not D is still incident in Mongolia: A time trend analysis (0)
- "A Case of Partial Response of Hepatocellular Carcinoma Induced by Concurrent Chemoradiation and Hepatic Arterial Infusion Chemotherapy after Trans-Arterial Chemoembolization (2014) (0)
- Hypoxic Apoptosis of Hepatocellular Carcinoma Triggers Apoptosis of Vascular Endothelial Cells (2014) (0)
- Basic, Research : The Difference of Ras Isoform in Liver Cancer (2013) (0)
- Contents Vol. 7, 2018 (2018) (0)
- 365 INACTIVE HBV CARRIERS: IS LIVER STIFFNESS MEASUREMENT USEFUL? A MULTICENTRE PROSPECTIVE STUDY (2011) (0)
- Advanced liver fibrosis predicts poor cardiovascular outcomes in patients with type 2 diabetes (2020) (0)
- 2175: Reappraisal of Radiotherapeutic Parameters in Terms of Predicting Liver Complication (2006) (0)
- Contents Vol. 88, 2013 (2013) (0)
- FRI-478-Survival outcomes of TACE in treatment-naive and recurrent HCC after curative resection: A propensity score-matched analysis (2019) (0)
- Implication of Automatically Analysed AFP-L 3 and PIVKA-II in the Diagnosis of Hepatocellular Carcinoma (2002) (0)
- Prospective Observational Cohort Study for the Durability of Oral Antiviral Treatment in Patients with Chronic Hepatitis B (2014) (0)
- A Case of Hepatocellular Carcinoma Araising from Dysplastic Nodule (2003) (0)
- Author Correction: Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals (2019) (0)
- Efficacy and safety of localized concurrent chemoradiation therapy and sorafenib sequential therapy in advanced hepatocellular carcinoma: A prospective phase II trial. (2017) (0)
- Longitudinal Assessment of Entecavir-induced Viral Load Reduction on Regulatory T Cells in Patients with Chronic Hepatitis B Virus Infection (2014) (0)
- Title Asian-Pacific consensus statement on the management ofchronic hepatitis B : a 2008 update (2008) (0)
- Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells (2015) (0)
- Safety and antiviral activity of pradefovir in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study (2006) (0)
- PO-0765: Efficacy of stereotactic body radiation therapy over radiofrequency ablation for HCC (2018) (0)
- Focal nodular hyperplasia-like nodules in a young man with congenital liver cirrhosis (2009) (0)
- SAT-224-Design and validation of a risk prediction model for hepatocellular carcinoma development after sustained virological response in chronic hepatitis C patients (2019) (0)
- [405] RIBOSOMAL PROTEINS OVER-EXPRESSED IN HBV-ASSOCIATED HEPATOCELLULAR CARCINOMA UPREGULATE THE HBx-INDUCED NF-icB SIGNALING (2007) (0)
- External Validation of HBV-related HCC Occurrence Risk Score Models in Patients with Chronic Hepatitis B Patients in Korea (2014) (0)
- Distinction of Non-alcoholic Steatohepatitis from Simple Steatosis by Controlled Attenuation Parameter and Liver Stiffness Using Transient Elastography in Patients with Non-alcoholic Fatty Liver Disease (2014) (0)
- [Inflammatory Hepatic Adenoma]. (2015) (0)
- 112 COMPARISON OF THE EFFECTS OF TERLIPRESSIN, SOMATOSTATIN, AND OCTREOTIDE WHEN COMBINED WITH ENDOSCOPIC TREATMENT IN ACUTE GASTROESOPHAGEAL VARICEAL BLEEDING: A MULTICENTER PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (2011) (0)
- The APPLE Association President's Message (2018) (0)
- Basic, Research : Rapid Induction of Liver Cancer using Hydrodynamic Transfection of Oncogene-encoding Plasmids (2013) (0)
- A Case of Rapidly Recurred Hepatocellular Carcinoma with Distant Metastasis after Surgical Resection (2015) (0)
- Development and validation of a predictive risk score for hepatocellular carcinoma in patients with chronic hepatitis B (2010) (0)
- 2176 : Radiation-Induced Hepatic Toxicity in Radiotherapy Combined With Chemotherapy for Hepatocellular Carcinoma (2006) (0)
- Hepatitis C Virus Attenuates Interferon-induced MHC Class I Expression via PKR Activation to Circumvent CD8 + T-cell Responses (2014) (0)
- 624 STAKEHOLDER INVOLVEMENT IN PRIORITY SETTING OF STRATEGIES TO IMPROVE HEPATOCELLULAR CARCINOMA POLICY IN ASIA (2011) (0)
- Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma (2018) (0)
- Serotonin signals through a gut-liver axis to regulate hepatic steatosis (2018) (0)
- SAT-392-Dickkopf-1 from hepatocellular carcinoma cells promotes the angiogenic potential of endothelial cells by activating the VEGFR-2 signaling pathway (2019) (0)
- Combined radiotherapy and hyperthermia for nonresectable hepatocellular carcinoma (1993) (0)
- Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial (2018) (0)
- THU-223-Development of an optimized risk prediction model for hepatocellular carcinoma in chronic hepatitis B patients with well-controlled viremia by antivirals (2019) (0)
- 306 RELATION OF INSULIN RESISTANCE AND HEPATIC STEATOSIS WITH ADVANCED HEPATIC FIBROSIS IN PATIENTS WITH GENOTYPE 1 OR 2/3 CHRONIC HEPATITIS C (2010) (0)
- Fibrotic Burden, Not Antiviral Agent, Determines Clinical Outcome in Chronic Hepatitis B Patients: A Propensity-Score Matched Analysis (2016) (0)
- Ultrasound Elastography-Based Prediction Model of Liver-Related Outcome (2017) (0)
- A case of hepatocellular carcinoma with metastasis to thalamus confirmed by biopsy (2007) (0)
- Poster Session—Hepatitis (Diagnosis/Pathogenesis/Therapy) (2006) (0)
- Hepatico-colonic Fistula after Radiofrequency Ablation in Hepatocellular Carcinoma (2014) (0)
- Histological Sub-classification of Cirrhosis Is Useful for Predicting Recurrence and Survival After Curative Resection of HBV-related Hepatocellular Carcinoma (2014) (0)
- 516 Impact of Entecavir Versus Lamivudine on Hepatic Covalently Closed-Circular DNA and Total Hepatic HBV DNA in Nucleoside-NaïVE HBeAg Positive Chronic Hepatitis B Patients (2013) (0)
- Erratum: Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model (2011) (0)
- Tenofovir versus Tenofovir plus Entecavir for Chronic Hepatitis B with Lamivudine-Resistance and Entecavir-Resistance (2016) (0)
- Delayed Post-polypectomy Bleeding in Patients with Chronic Liver Disease and Its Risk Factors (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kwang‐hyub Han?
Kwang‐hyub Han is affiliated with the following schools:
